New York · Hybrid · $145k–$189k/yr
Click Therapeutics
StageSeries D
Hiring pace5 roles / 90d
Founded2012
Team size51-200
HQNew York
IndustriesBiotechnology Research
About Click Therapeutics
Click Therapeutics, Inc. is positioned as a leading innovator of Digital Therapeutics. The company aims to provide patients everywhere access to safe and effective prescription digital therapeutics and is expanding and refining its shared platform technologies with novel cognitive, behavioral and neuromodulatory mechanisms of action. It employs advanced data-driven tools such as artificial intelligence and machine learning. Digital therapeutics developed on its platform address indications in psychiatry, neurology, oncology, cardiology and immunology. The company's prescription digital therapeutics are FDA-regulated.
Open positions · 5
Boston · Hybrid · $165k–$195k/yr
Visa sponsorshipBoston · On-site · $180k–$280k/yr
Boston · Hybrid · $150k–$220k/yr
Boston · Hybrid · $172k–$224k/yr
Visa sponsorshipCompany at a glance
Location
New York
Websiteclicktherapeutics.com
LinkedInLinkedIn
Location
Culture & values
Consistently named a best place to work.
Fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more.
Employees are united by a mission to provide patients everywhere access to safe and effective treatments.
Life at Click Therapeutics
Frequently asked questions
Companies similar to Click Therapeutics
EVANIUM
EVANIUM is a Regensburg, Germany–based life-science startup that aims to unleash the potential of plant compounds. The company uses its OPTISOLV platform to transform plant extracts into highly water-soluble, stable ingredients, serving customers in Germany and the USA and drawing international interest from Korea and beyond. With a 12-person team, EVANIUM has raised 2.2 million euros in seed funding led by Foodlabs and Phis, with investors including Böhringer Ingelheim and Razorfarm, and has earned an award at Vitafood. This year the company reported 350,000 euros in revenue and produced 2.5 tons of raw material, positioning itself as an innovative player in the plant-based ingredient market.
Biotechnology1-10
Arbio
Arbio, headquartered in Berlin, Germany, is building an AI-native property management platform for short-term rentals across Europe. It currently manages over 1,000 apartments and operates real properties in Berlin, Hamburg, Vienna, and Leipzig, with plans to expand to additional European cities. The company has raised a $36 million Series A funding and maintains an engineering team of five engineers. Arbio’s platform uses AI to observe, decide, and act on real-world property operations with humans in the loop, enabling AI-assisted management of short-term rental properties across Europe.
AI/ML51-200
Codeium
The company offers an AI-powered coding assistant for software development. The product is an AI-driven tool designed to assist with coding tasks within software development. By applying artificial intelligence, it supports the coding process. The focus is on AI-powered assistance for software development tasks.
SaaS51-200